TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

507 hedge funds and large institutions have $11.2B invested in Teva Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 129 increasing their positions, 209 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
507
Holders Change
-28
Holders Change %
-5.23%
% of All Funds
11.51%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.3%
New
98
Increased
129
Reduced
209
Closed
123
Calls
$617M
Puts
$807M
Net Calls
-$189M
Net Calls Change
+$66.1M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
$1.87B
2
Berkshire Hathaway
Berkshire Hathaway
Nebraska
$358M
3
Wellington Management Group
Wellington Management Group
Massachusetts
$903M
4
BC
Brahman Capital
New York
$188M
5
HCM
Highfields Capital Management
Massachusetts
$659M

Top Sellers

1
Bank of New York Mellon
Bank of New York Mellon
New York
$39.8M
2
Invesco
Invesco
Georgia
$43.1M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$20M
4
Macquarie Group
Macquarie Group
Australia
$3.68M
5
AllianceBernstein
AllianceBernstein
Tennessee
$142M
Name Holding Trade Value Shares
Change 		Shares
Change %
FIB
626
First Interstate Bank
Montana
– -$1K -65 Closed
MPWT
627
MassMutual Private Wealth & Trust
Connecticut
– -$458 -26 Closed
SA
628
SpiderRock Advisors
Delaware
– -$1K – –
22 23 24 25
26